Results 1 to 10 of about 6,092,576 (159)
Some of the next articles are maybe not open access.
The post-finasteride syndrome: possible etiological mechanisms and symptoms
International Journal of Impotence Research, 2023Finasteride and dutasteride, synthetic 5α-reductase inhibitors (5ARIs) are recommended in many guidelines for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms and alopecia despite a variety of side effects like sexual, neurological, psychiatric, endocrinological, metabolic and ophthalmological dysfunctions and the increased ...
Herman H. J. Leliefeld +2 more
openaire +2 more sources
Gynäkologische Endokrinologie, 2017
Das Post-Finasterid-Syndrom (PFS) beschreibt eine langfristige Storung der Sexualfunktion sowie psychische und kognitive Veranderungen, die wahrend oder nach der Behandlung einer androgenetischen Alopezie (AGA) mit 1 mg Finasterid pro Tag bzw. wahrend oder nach der Therapie einer benignen Prostatahyperplasie (BPH) mit 5 mg/Tag auftreten und nach ...
Herbert Kuhl, Inka Wiegratz
openaire +1 more source
Das Post-Finasterid-Syndrom (PFS) beschreibt eine langfristige Storung der Sexualfunktion sowie psychische und kognitive Veranderungen, die wahrend oder nach der Behandlung einer androgenetischen Alopezie (AGA) mit 1 mg Finasterid pro Tag bzw. wahrend oder nach der Therapie einer benignen Prostatahyperplasie (BPH) mit 5 mg/Tag auftreten und nach ...
Herbert Kuhl, Inka Wiegratz
openaire +1 more source
Trazodone associated with Clomiphene a proposal treatment for post finasteride syndrome
Magna Scientia Advanced Research and Reviews, 2023Erectile dysfunction caused by medications are probably caused by the disconnection of synaptic circuits responsible for linking libido to erection. For instance, it is well known that sexual dysfunction may occur in patients treated with finasteride, an inhibitor of the enzyme 5alpha-reductase, prescribed for androgenetic alopecia and benign prostatic
openaire +1 more source
Post-finasteride syndrome - a true clinical entity?
International Journal of Impotence ResearchThis review critically examines Post-Finasteride Syndrome (PFS), a condition eventually reported by men who have used finasteride for androgenetic alopecia or benign prostatic enlargement and experienced persistent adverse effects after discontinuation. We explore the clinical manifestations, including sexual dysfunction, neuropsychiatric symptoms, and
Simone Cilio +4 more
openaire +2 more sources
(135) Post-Finasteride Syndrome: A Case Presentation and Discussion
Journal of the Academy of Consultation-Liaison Psychiatry, 2022Daniel Wesley, Rachel Bronsther
openaire +1 more source
Physiology
Dopamine, a widely-distributed neurotransmitter in the brain and elsewhere, is important for regulating reward-motivated behavior, sexual impetus, concentration, pleasure, emotions, and genital arousal. Findings have previously implicated aberrant dopaminergic neurotransmission in mental disorders, as well as sexual and erectile dysfunction.
Churchill J Ihentuge, Antonei B Csoka
openaire +1 more source
Dopamine, a widely-distributed neurotransmitter in the brain and elsewhere, is important for regulating reward-motivated behavior, sexual impetus, concentration, pleasure, emotions, and genital arousal. Findings have previously implicated aberrant dopaminergic neurotransmission in mental disorders, as well as sexual and erectile dysfunction.
Churchill J Ihentuge, Antonei B Csoka
openaire +1 more source
ERECTILE HEMODYNAMICS ASESSMENT IN ED PATIENTS WITH SELF-DIAGNOSED POST-FINASTERIDE SYNDROME (PFS)
2023[Abstract Not Available]
Deveci, S. +3 more
openaire +1 more source
Re: Post-Finasteride Syndrome: A Surmountable Challenge for Clinicians
Journal of Urology, 2020openaire +2 more sources
‘Post-finasteride syndrome’: what to tell our female patients?
British Journal of Dermatology, 2018J.S. Mervis, L.J. Borda, M. Miteva
openaire +2 more sources